Columbia Asset Management’s Alterity Therapeutics ATHE Stock Holding History

Columbia Asset Management’s Portfolio ATHE Stock Details ATHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-653	Closed	-$35K	–	180
2015 Q3	$35K	Sell	653 -84	-11%	-$5.33K	0.01%	171
2015 Q2	$51K	Buy	737 +167	+29%	+$12.5K	0.02%	192
2015 Q1	$38K	Sell	570 -88	-13%	-$7.02K	0.01%	196
2014 Q4	$65K	Sell	658 -411	-38%	-$44.4K	0.03%	183
2014 Q3	$137K	Hold	1,069	–	–	0.06%	174
2014 Q2	$145K	Buy	1,069 +54	+5%	+$6.16K	0.06%	178
2014 Q1	$171K	Sell	1,015 -663	-40%	-$366K	0.07%	168
2013 Q4	$706K	Buy	+1,678	New	+$502K	0.31%	84

Other funds holding ATHE

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

GBA

Garrison Bradford & Associates New York $88.4M AUM 15.86% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

SBIA

Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Columbia Asset Management's ATHE Position: Q4 2015 in Review

Columbia Asset Management sold out of Alterity Therapeutics (ATHE) in Q4 2015, closing a stake of 653 shares — an estimated $35K sold.

Columbia Asset Management first reported a position in ATHE in Q4 2013 and held it in 8 quarters. The position peaked at $706K in Q4 2013. 24 funds tracked by Wall St. Rank hold ATHE as of Q4 2015.

Columbia Asset Management reported no remaining Alterity Therapeutics position as of Q4 2015 after selling out during the quarter.
Columbia Asset Management sold 653 Alterity Therapeutics shares in Q4 2015, an estimated $35K.
Columbia Asset Management first reported a position in Alterity Therapeutics in Q4 2013 and held it in 8 quarters.
Columbia Asset Management's Alterity Therapeutics position peaked at $706K in Q4 2013.
24 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q4 2015.

Based on Columbia Asset Management's 13F filing for Q4 2015, filed 8 Feb 2016.